Chiome Bioscience (TSE:4583) Other Stockholders Equity : 円12.9 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Chiome Bioscience Other Stockholders Equity?

Chiome Bioscience's Other Stockholders Equity for the quarter that ended in Mar. 2024 was 円12.9 Mil.

Chiome Bioscience's quarterly Other Stockholders Equity declined from Sep. 2023 (円22.1 Mil) to Dec. 2023 (円17.7 Mil) and declined from Dec. 2023 (円17.7 Mil) to Mar. 2024 (円12.9 Mil).

Chiome Bioscience's annual Other Stockholders Equity declined from Dec. 2021 (円35.4 Mil) to Dec. 2022 (円13.6 Mil) but then increased from Dec. 2022 (円13.6 Mil) to Dec. 2023 (円17.7 Mil).

Chiome Bioscience Other Stockholders Equity Historical Data

The historical data trend for Chiome Bioscience's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chiome Bioscience Other Stockholders Equity Chart

Chiome Bioscience Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

22.02

28.92

35.39

13.55

17.74

Chiome Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															12.62	12.62	22.09	17.74	12.95

Chiome Bioscience Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Chiome Bioscience Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Chiome Bioscience's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Chiome Bioscience (TSE:4583) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chiome Bioscience Inc (TSE:4583) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sumitomo Fudosan Nishi-shinjuku Building No.6, 3-12-1, Honmachi, Shibuya-ku, Tokyo, JPN, 151-0071

Website

http://www.chiome.co.jp

Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Chiome Bioscience (TSE:4583) Headlines

No Headlines